Counterfeit Drug Prevention Act of 2006
Summary
The Counterfeit Drug Prevention Act of 2006 (H.R. 5156) proposes to significantly increase federal criminal penalties for individuals who knowingly manufacture, sell, or distribute counterfeit medications. Under this bill, offenders could face up to 20 years in prison, with the possibility of a life sentence if a counterfeit drug is found to be the direct cause of a consumer's death. For everyday citizens, this legislation aims to enhance public safety by creating a stronger legal deterrent against the entry of fraudulent and potentially dangerous drugs into the healthcare supply chain.
AI-generated summary
Lifecycle of the Bill
No events recorded for this stage yet.